Browse > Article

Effect of Stilbenoids on TNF-${\alpha}$-induced Adipokine Secretion  

Ahn, Ji-Yun (Food Function Research Center, Korea Food Research Institute)
Lee, Hyun-Jung (Food Function Research Center, Korea Food Research Institute)
Kim, Sun-A (Food Function Research Center, Korea Food Research Institute)
Ha, Tae-Youl (Food Function Research Center, Korea Food Research Institute)
Publication Information
Food Science and Biotechnology / v.18, no.5, 2009 , pp. 1284-1287 More about this Journal
Abstract
Tumor necrosis factor (TNF)-${\alpha}$ is chronically elevated in adipose tissues of obese rodents and humans. Increased levels of TNF-${\alpha}$ have been implicated in both the induction of atherogenic adipokines, such as plasminogen activator inhibitor (PAI)-1, and the inhibition of the anti-atherogenic adipokine, adiponectin. In this study, we investigated the effects of trans-stilbene, piceatannol, rhaponticin, and piceid on the TNF-${\alpha}$-induced atherogenic changes of adipokines in 3T3-L1 cells. Exposure to TNF-${\alpha}$ for 24 hr increased PAI-1 secretion and decreased adiponectin secretion. Among stilbenoids, piceatannol significantly inhibited the increased secretion of PAI-1 induced by TNF-${\alpha}$. Adiponectin secretion decreased by TNF-${\alpha}$ was recovered after trans-stilbene and rhaponticin treatments. Our results showed that stilbenoids exerted different effects on TNF-${\alpha}$-induced changes in adipokines secretion in 3T3-L1 adipocytes according to their structural characteristics.
Keywords
stilbenoid; 3T3-L1 adipocyte; plasminogen activator inhibitor-1; adiponectin;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Bavaresco L, Fregoni C, Cantu E, Trevisan M. Stilbene compounds: From the grapevine to wine. Drug Exp. Clin. Res. 25: 57-63 (1999)
2 Hibasami H, Takagi K, Ishii T, Tsujikawa M, Imai N, Honda I. Induction of apoptosis by rhapontin having stilbene moiety, a component of rhubarb (Rheum officinale Baillon) in human stomach cancer KATO III cells. Oncol. Rep. 18: 347-351 (2007)   PUBMED
3 Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7: 941-946 (2001)   DOI   ScienceOn
4 Skurk T, Hauner H. Obesity and impaired fibrinolysis: Role of adipose production of plasminogen activator inhibitor-1. Int. J. Obes. Relat. Metab. Disord. 28: 1357-1364 (2004)   DOI   ScienceOn
5 Cheong HS, Ryu Y, Kim KM. Anti-allergic action of resveratrol and related hydroxyl stilbenes. Planta Med. 65: 266-268 (1999)   DOI   ScienceOn
6 Regev-Shoshani G, Shoseyov O, Bilkis I, Kerem Z. Glycosylation of resveratrol protects it from enzymic oxidation. Biochem. J. 374: 157-163 (2003)   DOI   ScienceOn
7 Cernkovich ER, Deng J, Bond MC, Combs TP, Harp JB. Adiposespecific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity. Endocrinology 149: 1581- 1590 (2008)   DOI   ScienceOn
8 Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, Arichi S. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem. Pharm. Bull. 30: 1766-1770 (1982)   DOI   PUBMED   ScienceOn
9 Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscl. Throm. Vas. 24: 29-33 (2004)   DOI   ScienceOn
10 Ahn J, Lee H, Kim S, Ha T. Resveratrol inhibits TNF-α-induced changes of adipokines in 3T3-L1 adipocytes. Biochem. Bioph. Res. Co. 364: 972-977 (2007)   DOI   ScienceOn
11 Yamamoto H, Schoonjans K, Auwerx J. Sirtuin functions in health and disease. Mol. Endocrinol. 21: 1745-755 (2007)   DOI   ScienceOn
12 Lam RY, Woo AY, Leung PS, Cheng CH. Antioxidant actions of phenolic compounds found in dietary plants on low-density lipoprotein and erythrocytes in vitro. J. Am. Coll. Nutr. 26: 233-242 (2007)   PUBMED
13 Samad F, Yamamoto K, Loskutoff DJ. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo: Induction by tumor necrosis factor-α and lipopolysaccharide. J. Clin. Invest. 97: 37-46 (1996)   DOI   PUBMED   ScienceOn
14 Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity. Nat. Med. 2: 800-803 (1996)   DOI   ScienceOn
15 Hung LM, Chen JK, Lee RS, Liang HC, Su MJ. Beneficial effects of astringinin, a resveratrol analogue on the ischemia and reperfusion damage in rat heart. Free Radial Bio. Med. 30: 877-883 (2001)   DOI   ScienceOn
16 Juhan-Vague I, Alessi MC, Mavri A, Morange PE. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance, and vascular risk. J. Thromb. Haemost. 1: 1575-1579 (2003)   DOI   ScienceOn
17 Maahs DM, Ogden LG, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson JE, Ehrlich J, Eckel RH, Rewers M. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 111: 747-753 (2005)   DOI   ScienceOn
18 Stephens JM, Morrison RF, Pilch PF. The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J. Biol. Chem. 271: 10441-10444 (1996)   DOI   ScienceOn
19 Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, Leid M, McBurney MW, Guarente L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPARgamma. Nature 429: 771-776 (2004)   DOI   PUBMED   ScienceOn
20 Waffo-Teguo P, Fauconneau B, Deffieux G, Huguet F, Vercauteren J, Merillon JM. Isolation, identification, and antioxidant activity of three stilbene glucosides newly extracted from Vitis vinifera cell cultures. J. Nat. Prod. 61: 655-657 (1998)   DOI   ScienceOn
21 James PT, Rigby N, Leach R. International obesity task force, The obesity epidemic, metabolic syndrome, and future prevention strategies. Eur. J. Cardiovasc. Prev. Rehabil. 11: 3-8 (2004)   DOI   ScienceOn
22 Lam KS, Xu A. Adiponectin: Protection of the endothelium. Curr. Diab. Rep. 5: 254-259 (2005)   DOI   ScienceOn
23 Lyon CJ, Hsueh WA. Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease. Am. J. Med. 115: S62- S68 (2003)
24 Su L, David M. Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol. J. Biol. Chem. 275: 12661-12666 (2000)   DOI   ScienceOn
25 Deng J, Hua K, Lesser SS, Harp JB. Activation of signal transducer and activator of transcription-3 during proliferative phases of 3T3- L1 adipogenesis. Endocrinology 141: 2370-2376 (2000)   DOI   ScienceOn
26 Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard- Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. New Engl. J. Med. 355: 763-778 (2006)   DOI   ScienceOn
27 Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J. Clin. Endocr. Metab. 89: 2595-2600 (2004)   DOI   ScienceOn
28 Trayhurn P, Wood IS. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Brit. J. Nutr. 92: 347-355 (2004)   DOI   ScienceOn
29 Piver B, Fer M, Vitrac X, Merllon JM, Dreano Y, Berthow F, Lucas D. Involvement of cytochrome P4501A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochem. Pharmacol. 68: 773-782 (2004)   DOI   ScienceOn
30 Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360: 57-58 (2002)   DOI   ScienceOn
31 Waffo-Teguo P, Hawthorne ME, Cuendet M, Merillon JM, Kinghorn AD, Pezzuto JM, Mehta RG. Potential cancerchemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures. Nutr. Cancer 40: 173-179 (2001)   DOI   ScienceOn
32 Fabris S, Momo F, Ravagnan G, Stevanato R. Antioxidant properties of resveratrol and piceid on lipid peroxidation in micelles and monolamellar liposomes. Biophys. Chem. 135: 76-83 (2008)   DOI   PUBMED   ScienceOn
33 Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y. PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50: 2094-2099 (2001)   DOI   ScienceOn
34 Ferrigi NR, McLanghlin JL, Powell RG, Smith CR. Use of potato disc and brine shrimp bioassays to detect activity and isolate piceatannol as the antileukemic principle from the seeds of Euphorbia Lagascae. J. Nat. Prod. 47: 347-352 (1984)   DOI   PUBMED
35 Romero-Perez AI, Ibern-Gomez M, Lamuela-Raventos RM, de la Torre-Boronat MC. Piceid, the major resveratrol derivative in grape juices. J. Agr. Food Chem. 47: 1533-1536 (1999)   DOI   ScienceOn
36 Thakkar K, Geahlen RL, Cushman M. Synthesis and proteintyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol. J. Med. Chem. 36: 2950-2955 (1993)   DOI   ScienceOn
37 Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95: 2409-2415 (1995)   DOI   ScienceOn